Logo image of CZR

CAESARS ENTERTAINMENT INC (CZR) Stock Fundamental Analysis

NASDAQ:CZR - Nasdaq - US12769G1004 - Common Stock - Currency: USD

25.51  +0.76 (+3.07%)

After market: 25.5 -0.01 (-0.04%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CZR. CZR was compared to 136 industry peers in the Hotels, Restaurants & Leisure industry. CZR has a bad profitability rating. Also its financial health evaluation is rather negative. CZR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CZR had negative earnings in the past year.
CZR had a positive operating cash flow in the past year.
In the past 5 years CZR reported 4 times negative net income.
CZR had a positive operating cash flow in 4 of the past 5 years.
CZR Yearly Net Income VS EBIT VS OCF VS FCFCZR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

With a Return On Assets value of -0.85%, CZR is not doing good in the industry: 66.18% of the companies in the same industry are doing better.
CZR has a Return On Equity (-6.69%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 5.93%, CZR is in line with its industry, outperforming 52.94% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CZR is significantly below the industry average of 15.70%.
The 3 year average ROIC (5.76%) for CZR is below the current ROIC(5.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.85%
ROE -6.69%
ROIC 5.93%
ROA(3y)-0.39%
ROA(5y)-1.74%
ROE(3y)-4.54%
ROE(5y)-14.28%
ROIC(3y)5.76%
ROIC(5y)4.32%
CZR Yearly ROA, ROE, ROICCZR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

Looking at the Operating Margin, with a value of 20.23%, CZR is in the better half of the industry, outperforming 78.68% of the companies in the same industry.
In the last couple of years the Operating Margin of CZR has grown nicely.
Looking at the Gross Margin, with a value of 49.08%, CZR is in line with its industry, outperforming 56.62% of the companies in the same industry.
In the last couple of years the Gross Margin of CZR has remained more or less at the same level.
Industry RankSector Rank
OM 20.23%
PM (TTM) N/A
GM 49.08%
OM growth 3Y4.31%
OM growth 5Y2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.56%
CZR Yearly Profit, Operating, Gross MarginsCZR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1

2. Health

2.1 Basic Checks

CZR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CZR has less shares outstanding
Compared to 5 years ago, CZR has more shares outstanding
CZR has a worse debt/assets ratio than last year.
CZR Yearly Shares OutstandingCZR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CZR Yearly Total Debt VS Total AssetsCZR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CZR has an Altman-Z score of 0.55. This is a bad value and indicates that CZR is not financially healthy and even has some risk of bankruptcy.
CZR's Altman-Z score of 0.55 is on the low side compared to the rest of the industry. CZR is outperformed by 76.47% of its industry peers.
A Debt/Equity ratio of 6.00 is on the high side and indicates that CZR has dependencies on debt financing.
CZR has a worse Debt to Equity ratio (6.00) than 61.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 6
Debt/FCF N/A
Altman-Z 0.55
ROIC/WACC1.07
WACC5.56%
CZR Yearly LT Debt VS Equity VS FCFCZR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 0.77 indicates that CZR may have some problems paying its short term obligations.
With a Current ratio value of 0.77, CZR perfoms like the industry average, outperforming 41.91% of the companies in the same industry.
CZR has a Quick Ratio of 0.77. This is a bad value and indicates that CZR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.75, CZR perfoms like the industry average, outperforming 45.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.75
CZR Yearly Current Assets VS Current LiabilitesCZR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

The earnings per share for CZR have decreased by -2.78% in the last year.
Looking at the last year, CZR shows a decrease in Revenue. The Revenue has decreased by -2.45% in the last year.
CZR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.78% yearly.
EPS 1Y (TTM)-2.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.71%
Revenue 1Y (TTM)-2.45%
Revenue growth 3Y5.52%
Revenue growth 5Y34.78%
Sales Q2Q%-0.92%

3.2 Future

The Earnings Per Share is expected to grow by 56.53% on average over the next years. This is a very strong growth
CZR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.79% yearly.
EPS Next Y239.22%
EPS Next 2Y107.83%
EPS Next 3Y69.12%
EPS Next 5Y56.53%
Revenue Next Year3.22%
Revenue Next 2Y2.86%
Revenue Next 3Y2.72%
Revenue Next 5Y3.79%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CZR Yearly Revenue VS EstimatesCZR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B
CZR Yearly EPS VS EstimatesCZR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5 -10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CZR. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 24.76, CZR is valued on the expensive side.
CZR's Price/Forward Earnings ratio is in line with the industry average.
CZR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.08, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 24.76
CZR Price Earnings VS Forward Price EarningsCZR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CZR is valued a bit cheaper than the industry average as 72.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.22
CZR Per share dataCZR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CZR's earnings are expected to grow with 69.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y107.83%
EPS Next 3Y69.12%

0

5. Dividend

5.1 Amount

No dividends for CZR!.
Industry RankSector Rank
Dividend Yield N/A

CAESARS ENTERTAINMENT INC

NASDAQ:CZR (4/17/2025, 8:11:32 PM)

After market: 25.5 -0.01 (-0.04%)

25.51

+0.76 (+3.07%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners103.97%
Inst Owner Change0%
Ins Owners0.79%
Ins Owner Change3.19%
Market Cap5.41B
Analysts79.05
Price Target48.55 (90.32%)
Short Float %8.39%
Short Ratio3.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.2%
Min EPS beat(2)-132.55%
Max EPS beat(2)136.94%
EPS beat(4)1
Avg EPS beat(4)-334.67%
Min EPS beat(4)-1227.16%
Max EPS beat(4)136.94%
EPS beat(8)2
Avg EPS beat(8)-1507.65%
EPS beat(12)3
Avg EPS beat(12)-1064.82%
EPS beat(16)4
Avg EPS beat(16)-824.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-2.68%
Max Revenue beat(2)-1.58%
Revenue beat(4)0
Avg Revenue beat(4)-2.77%
Min Revenue beat(4)-4.26%
Max Revenue beat(4)-1.58%
Revenue beat(8)2
Avg Revenue beat(8)-1.35%
Revenue beat(12)4
Avg Revenue beat(12)-1.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.12%
PT rev (1m)-1.92%
PT rev (3m)-10.73%
EPS NQ rev (1m)3.57%
EPS NQ rev (3m)-396.25%
EPS NY rev (1m)-9.97%
EPS NY rev (3m)-18.62%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)-1.99%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 24.76
P/S 0.48
P/FCF N/A
P/OCF 5.03
P/B 1.3
P/tB N/A
EV/EBITDA 8.22
EPS(TTM)-0.74
EYN/A
EPS(NY)1.03
Fwd EY4.04%
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)5.07
OCFY19.88%
SpS53.04
BVpS19.61
TBVpS-49.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.85%
ROE -6.69%
ROCE 7.5%
ROIC 5.93%
ROICexc 6.1%
ROICexgc 12.21%
OM 20.23%
PM (TTM) N/A
GM 49.08%
FCFM N/A
ROA(3y)-0.39%
ROA(5y)-1.74%
ROE(3y)-4.54%
ROE(5y)-14.28%
ROIC(3y)5.76%
ROIC(5y)4.32%
ROICexc(3y)5.94%
ROICexc(5y)4.47%
ROICexgc(3y)12.3%
ROICexgc(5y)9.19%
ROCE(3y)7.29%
ROCE(5y)5.47%
ROICexcg growth 3Y12.39%
ROICexcg growth 5Y-1.47%
ROICexc growth 3Y12.76%
ROICexc growth 5Y-4.07%
OM growth 3Y4.31%
OM growth 5Y2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.56%
F-Score4
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 6
Debt/FCF N/A
Debt/EBITDA 6.93
Cap/Depr 99.02%
Cap/Sales 11.66%
Interest Coverage 2.16
Cash Conversion 29.87%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.75
Altman-Z 0.55
F-Score4
WACC5.56%
ROIC/WACC1.07
Cap/Depr(3y)93.85%
Cap/Depr(5y)77.92%
Cap/Sales(3y)10.59%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.71%
EPS Next Y239.22%
EPS Next 2Y107.83%
EPS Next 3Y69.12%
EPS Next 5Y56.53%
Revenue 1Y (TTM)-2.45%
Revenue growth 3Y5.52%
Revenue growth 5Y34.78%
Sales Q2Q%-0.92%
Revenue Next Year3.22%
Revenue Next 2Y2.86%
Revenue Next 3Y2.72%
Revenue Next 5Y3.79%
EBIT growth 1Y-10.92%
EBIT growth 3Y10.07%
EBIT growth 5Y38.4%
EBIT Next Year76.62%
EBIT Next 3Y23.32%
EBIT Next 5Y16.79%
FCF growth 1Y-145.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-40.57%
OCF growth 3Y-3.11%
OCF growth 5Y28.03%